s.poulsen
TL3 Regular · Ljubljana, SI
Clinician. Posts general information only, and says so every time.
Joined 26 August 2024 · last posted 2d · groups: clinicians
136 posts, newest first. Showing up to 150.
-
About the Adverse events category Replied, post #7 · Safety › Adverse events · 26 Jul 2026 · 28 likes Worth separating two things that post #3 runs together. Serious and unexpected events are the ones to document and report. Serious means hospitalization-level serious.…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #63 · Practice › Interactions · 24 Jul 2026 · 0 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #83 · Practice › Dosing & titration · 21 Jul 2026 · 1 like The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #82 · Nutrition & Training › Protein & intake · 19 Jul 2026 · 25 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #96 · Analytics › Home & field testing · 17 Jul 2026 · 10 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #7 · Practice › Interactions · 8 Jul 2026 · 23 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Prescription requirements and telehealth models — a second dataset Replied, post #93 · Sourcing › Regulatory · 6 Jul 2026 · 14 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
Naming conventions for research peptides and the confusion they cause Replied, post #23 · Compounds › Other compounds · 30 Jun 2026 · 1 like post #22 answers the question as asked. The question underneath it is different. When "no data" is the complete and final answer: if there is no published human data on…
-
Documenting a supplier's response to a discrepancy Replied, post #22 · Sourcing › Vendor reports · 24 Jun 2026 · 8 likes Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…
-
Historical amylin analogues and what happened to them Replied, post #23 · Compounds › Cagrilintide & amylin analogues · 24 Jun 2026 · 1 like Cagrilintide alone is discussed less than in combination because the published data is almost entirely from combination trials. The phase 2 combination data was…
-
GLP-1 receptor distribution: central and peripheral Replied, post #74 · Pharmacology › Receptor biology · 21 Jun 2026 · 1 like Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
-
Packaging that arrived damaged: documenting it properly Replied, post #27 · Sourcing › Logistics · 18 Jun 2026 · 9 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
-
Prescription portability between countries Replied, post #68 · Access › International · 18 Jun 2026 · 0 likes post #67 answers the question as asked. The question underneath it is different. Regulatory position dates: a regulatory position is only current as of when it was…
-
What to include when your question involves a chromatogram — one year on Replied, post #40 · Start Here › How to Ask · 17 Jun 2026 · 0 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #40 · Start Here › Welcome · 14 Jun 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #31 · Pharmacology › Formulation chemistry · 13 Jun 2026 · 0 likes I read post #29 twice before replying, because I had assumed the opposite. Buffers and pH: the pH of a solution is buffered to maintain stability. The buffer system…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #53 · Compounds › Semaglutide · 6 Jun 2026 · 20 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #78 · Sourcing › Red flags · 6 Jun 2026 · 32 likes Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #38 · Analytics › Home & field testing · 4 Jun 2026 · 23 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
Reading a trial's population section before its results Replied, post #45 · Evidence › Trials · 23 May 2026 · 21 likes Picking up post #42: that is the part I would want checked first. Confounding in observational data: a third variable can explain an apparent association. In a…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #35 · Clinical › Bloodwork · 22 May 2026 · 29 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
Why the timeline is on the right and not the left — what changed since Replied, post #37 · Meta › Site feedback · 16 May 2026 · 22 likes Display issues: broken layouts, images not loading, text overlapping — report with the browser and device you were using. Display bugs are platform-specific.
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #25 · Analytics › HPLC & UHPLC · 11 May 2026 · 0 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #29 · Compounds › Tirzepatide · 7 May 2026 · 0 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #34 · Practice › Reconstitution · 4 May 2026 · 1 like Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #20 · Compounds › Repair & healing peptides · 3 May 2026 · 17 likes Picking up post #17: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #12 · Practice › Storage & stability · 1 May 2026 · 22 likes Picking up post #9: that is the part I would want checked first. Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based…
-
Request: show the solution author in the topic list — what changed since Replied, post #7 · Meta › Feature requests · 30 Apr 2026 · 0 likes Worth separating two things that post #3 runs together. Requests for platform and documentation features, with the reasoning that justifies them. If you think the site…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #9 · Compounds › Tirzepatide · 29 Apr 2026 · 2 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #4 · Compounds › Semaglutide · 22 Apr 2026 · 12 likes the opening post answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #38 · Evidence › Journal club · 14 Apr 2026 · 12 likes On post #34 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
A fridge failure and how I assessed the contents afterwards Replied, post #7 · Devices › Cold chain · 13 Apr 2026 · 3 likes I read post #5 twice before replying, because I had assumed the opposite. Travel with medication: carrying a vial across borders requires planning if temperatures will…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #24 · Practice › Interactions · 11 Apr 2026 · 5 likes Picking up post #21: that is the part I would want checked first. Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #51 · Practice › Reconstitution · 22 Mar 2026 · 5 likes post #50 answers the question as asked. The question underneath it is different. Choosing a concentration on purpose rather than by accident: starting with "I want to…
-
Grapefruit: why this class is not the class that cares Replied, post #58 · Practice › Interactions · 20 Mar 2026 · 3 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #107 · Lounge › Introductions · 18 Mar 2026 · 1 like Coming back to post #105, because the follow-up matters more than the original answer. No judgment: people come to this community from all backgrounds and with all…
-
CJC-1295 with and without DAC: what the modification does Replied, post #11 · Compounds › Secretagogues & GH axis · 11 Mar 2026 · 1 like Worth separating two things that post #7 runs together. Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose…
-
Guidelines revision: what changed and why — one year on Replied, post #80 · Meta › Announcements · 9 Mar 2026 · 23 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #20 · Analytics › COA interpretation · 26 Feb 2026 · 3 likes I read post #18 twice before replying, because I had assumed the opposite. When a document puts the specification in the result column, it has told you the release…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #127 · Practice › Dosing & titration · 21 Feb 2026 · 27 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Dead volume across syringe and needle combinations Replied, post #75 · Devices › Syringes & needles · 20 Feb 2026 · 0 likes I read post #73 twice before replying, because I had assumed the opposite. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #93 · Wellbeing › Mental health · 18 Feb 2026 · 15 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #48 · Analytics › Method validation · 13 Feb 2026 · 21 likes On post #44 — agreed on the reasoning, with one qualification. Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #41 · Start Here › Welcome · 11 Feb 2026 · 28 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
Trifluoroacetate content and its consequences Replied, post #91 · Analytics › Impurities & related substances · 6 Feb 2026 · 20 likes Picking up post #88: that is the part I would want checked first. Truncation products: fragments from incomplete synthesis or from degradation. They elute quite…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #70 · Access › Pricing · 24 Jan 2026 · 2 likes Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #7 · Practice › Side effects · 31 Dec 2025 · 2 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
-
Reading an interaction checker output critically Replied, post #67 · Practice › Interactions · 15 Dec 2025 · 0 likes Picking up post #64: that is the part I would want checked first. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #23 · Compounds › Retatrutide · 12 Dec 2025 · 13 likes On post #19 — agreed on the reasoning, with one qualification. Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #103 · Sourcing › Vendor reports · 3 Dec 2025 · 9 likes Worth separating two things that post #99 runs together. Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from…
-
Reading an interaction checker output critically Replied, post #56 · Practice › Interactions · 2 Dec 2025 · 0 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #2 · Practice › Administration · 30 Nov 2025 · 3 likes This follows the opening post rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Airline travel with a temperature-sensitive injectable Replied, post #18 · Devices › Cold chain · 28 Nov 2025 · 1 like Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque containers reduce light exposure. For short-term storage, keeping the vial in its…
-
Tracking that stops updating and then resumes Replied, post #48 · Sourcing › Logistics · 21 Nov 2025 · 24 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #34 · Start Here › How to Ask · 20 Nov 2025 · 28 likes I read post #32 twice before replying, because I had assumed the opposite. What you have already read matters. Saying "I read the maintained page on this and I still…
-
Titles that describe the question, not the situation Replied, post #153 · Start Here › How to Ask · 19 Nov 2025 · 25 likes What you have already read matters. Saying "I read the maintained page on this and I still have a gap" tells people they do not need to point you at the same resource…
-
[2026 update] Splitting an overlong document into two Replied, post #47 · Documentation › Wiki requests · 4 Nov 2025 · 7 likes Translation suggestions: if a maintained page should exist in another language, suggesting it here helps the maintainers prioritise multilingual work.
-
New subcategory: rationale and scope Replied, post #109 · Meta › Announcements · 24 Oct 2025 · 0 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #4 · Start Here › Welcome · 11 Oct 2025 · 1 like the opening post is right about the mechanism and I think understates the practical bit. Your introduction is well framed. You have given enough context that people can…
-
High-resolution MS on aggregates and what it can see Replied, post #79 · Analytics › Mass spectrometry · 28 Sep 2025 · 11 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #81 · Devices › Cold chain · 25 Sep 2025 · 18 likes Shipment during summer or to hot climates: consider shipping to a cold-storage facility rather than to home if temperatures will be high. Alternatively, time shipment…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #43 · Pharmacology › Receptor biology · 23 Sep 2025 · 6 likes Coming back to post #41, because the follow-up matters more than the original answer. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure…
-
Which panel is worth repeating and which is worth ignoring Replied, post #118 · Clinical › Bloodwork · 22 Sep 2025 · 13 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
Payment method and the leverage it gives you, ranked Replied, post #52 · Sourcing › Payments · 22 Sep 2025 · 15 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Payment method and the leverage it gives you, ranked Replied, post #45 · Sourcing › Payments · 20 Sep 2025 · 32 likes post #44 answers the question as asked. The question underneath it is different. Escrow services: some third-party services hold payment until the buyer confirms…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #65 · Data & Tools › Datasets · 9 Sep 2025 · 2 likes I read post #63 twice before replying, because I had assumed the opposite. Combining data from different sources: datasets from this site are not directly comparable to…
-
Second pass at: Programming during a large energy deficit Replied, post #3 · Nutrition & Training › Resistance training · 8 Sep 2025 · 7 likes Post-weight-loss training: once weight loss is complete and energy deficit ends, training can shift to building again. The transition from preservation mode to building…
-
Gauge and length selection for subcutaneous injection Replied, post #27 · Devices › Syringes & needles · 6 Sep 2025 · 22 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
-
Confounding by indication, explained with a concrete example Replied, post #18 · Evidence › Study critique · 2 Sep 2025 · 18 likes What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #115 · Compounds › Tirzepatide · 30 Aug 2025 · 10 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #65 · Compounds › Retatrutide · 26 Aug 2025 · 4 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #17 · Compounds › Tirzepatide · 26 Aug 2025 · 10 likes This follows post #14 rather than contradicting it. Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #31 · Practice › Storage & stability · 20 Aug 2025 · 1 like Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #34 · Evidence › Journal club · 14 Aug 2025 · 25 likes This follows post #31 rather than contradicting it. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent…
-
Second pass at: LOD and LOQ: definitions people get wrong Started this topic · Analytics › Method validation · 13 Aug 2025 · 0 likes Posting this under the heading it deserves: Second pass at: LOD and LOQ: definitions people get wrong Everything below is what sits behind that. Working through the…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #18 · Analytics › COA interpretation · 10 Aug 2025 · 0 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #37 · Practice › Reconstitution · 6 Aug 2025 · 13 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
How to research a compound with no human data without deceiving yourself Replied, post #45 · Compounds › Other compounds · 1 Aug 2025 · 0 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
-
An emergency department visit, described afterwards Replied, post #48 · Safety › Adverse events · 30 Jul 2025 · 24 likes Pancreatitis is a genuine serious adverse event to know: severe epigastric pain, back pain, elevated lipase (≥3× upper limit of normal). If this constellation appears,…
-
Comparing my trajectory with the trial curves, carefully Replied, post #28 · Outcomes › Progress reports · 25 Jul 2025 · 22 likes Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
-
Asking about a compound your prescriber has not heard of Replied, post #104 · Clinical › Prescriber conversations · 24 Jul 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #30 · Compounds › Cagrilintide & amylin analogues · 22 Jul 2025 · 31 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #73 · Compounds › Semaglutide · 17 Jul 2025 · 4 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #10 · Practice › Dosing & titration · 10 Jul 2025 · 0 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Pen wastage and its effect on real cost — the long version Replied, post #3 · Access › Pricing · 7 Jul 2025 · 6 likes Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial volume, and whether you are using a vial or a pen.
-
Repeatability versus intermediate precision Replied, post #107 · Analytics › Method validation · 30 Jun 2025 · 8 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #31 · Compounds › Cagrilintide & amylin analogues · 22 Jun 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #39 · Evidence › Journal club · 15 Jun 2025 · 1 like post #38 is right about the mechanism and I think understates the practical bit. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the…
-
Half-life, steady state, and accumulation worked through Replied, post #57 · Pharmacology › Pharmacokinetics · 2 Jun 2025 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Pre-registering a personal experiment, seriously Replied, post #85 · Research Methods › N-of-1 designs · 2 Jun 2025 · 23 likes Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of measurements, or after a defined condition is met).…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #6 · Documentation › Doc review · 27 May 2025 · 32 likes Evidence synthesis requests: if you think a page should summarise the state of evidence on a question, and you think the information exists but is scattered, suggest…
-
Second pass at: What a reversed-phase purity number actually is Replied, post #2 · Analytics › HPLC & UHPLC · 22 May 2025 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. Area percent is not mass percent. It is a proportion of absorbance,…
-
Pregnancy as an absolute contraindication Replied, post #43 · Safety › Contraindications · 18 May 2025 · 3 likes Disordered eating history: appetite suppression can trigger relapse in people with history of anorexia, bulimia, or other eating disorders. This is a relative…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #90 · Sourcing › Independent verification · 13 May 2025 · 29 likes Picking up post #87: that is the part I would want checked first. Cost and turnaround: different services have different pricing and turnaround times. Janoshik's…
-
Follow-up: Documentation that appears only after payment Replied, post #69 · Sourcing › Red flags · 12 May 2025 · 2 likes Picking up post #66: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
A supplier that answers analytical questions with restated claims Replied, post #71 · Sourcing › Red flags · 6 May 2025 · 32 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
-
Coming back to: Official shortage notices and what they authorise Started this topic · Access › Shortages · 2 May 2025 · 3 likes Official shortage notices and what they authorise Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the…
-
Antibiotics and a course of something with delayed emptying Replied, post #26 · Practice › Interactions · 23 Apr 2025 · 2 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #77 · Compounds › Semaglutide · 14 Apr 2025 · 0 likes On post #73 — agreed on the reasoning, with one qualification. The mass figure differs between sources because of how the different entities report it. The monoisotopic…
-
Reading a trial's population section before its results — does this still hold? Replied, post #7 · Evidence › Trials · 13 Apr 2025 · 7 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Checking someone else's arithmetic: a worked example thread Replied, post #37 · Practice › Reconstitution · 10 Apr 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Requesting a page: what makes a good request Replied, post #48 · Documentation › Wiki requests · 7 Apr 2025 · 30 likes post #47 answers the question as asked. The question underneath it is different. Format suggestions: if you think a maintained page could be clearer in its presentation…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #62 · Compounds › Cagrilintide & amylin analogues · 30 Mar 2025 · 28 likes post #61 answers the question as asked. The question underneath it is different. Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #28 · Practice › Reconstitution · 26 Mar 2025 · 0 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #115 · Access › International · 22 Mar 2025 · 29 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #59 · Practice › Reconstitution · 21 Mar 2025 · 15 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #153 · Sourcing › Vendor reports · 19 Mar 2025 · 13 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #98 · Analytics › COA interpretation · 19 Mar 2025 · 10 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
Maintainer handover: how it works Replied, post #23 · Meta › Wiki maintenance · 14 Mar 2025 · 0 likes Outdated external links: if a maintained page links to external sources and those links are broken or pages have moved, reporting that helps keep the page current.
-
Coverage for the indication versus for the drug — a second dataset Replied, post #9 · Access › Insurance & coverage · 9 Mar 2025 · 16 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
Filing a first vendor report: a worked example Replied, post #3 · Sourcing › Vendor reports · 8 Mar 2025 · 17 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #102 · Sourcing › Regulatory · 4 Mar 2025 · 9 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #28 · Compounds › Semaglutide · 4 Mar 2025 · 1 like The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Deamidation and the close-eluting pair it produces Replied, post #4 · Analytics › Impurities & related substances · 2 Mar 2025 · 29 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
Second pass at: Regression to the mean in progress reports Replied, post #71 · Research Methods › Statistics · 28 Feb 2025 · 12 likes Picking up post #68: that is the part I would want checked first. Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one…
-
Protein density versus volume when you cannot eat much Replied, post #54 · Nutrition & Training › Protein & intake · 2 Feb 2025 · 0 likes This follows post #51 rather than contradicting it. Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is…
-
What changed in 2026, by region Replied, post #114 · Access › International · 1 Feb 2025 · 1 like Worth separating two things that post #110 runs together. Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on…
-
A page that has drifted out of date and needs a maintainer Replied, post #57 · Documentation › Wiki requests · 28 Jan 2025 · 1 like Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
-
Isotonicity and what happens when you get it wrong Replied, post #31 · Pharmacology › Formulation chemistry · 17 Jan 2025 · 23 likes Coming back to post #29, because the follow-up matters more than the original answer. Antioxidants: compounds that prevent oxidation (which damages peptides) are…
-
Coming back to: When to suspect the method rather than the sample Replied, post #113 · Analytics › Method validation · 22 Dec 2024 · 5 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #6 · Pharmacology › Receptor biology · 16 Dec 2024 · 0 likes This follows post #3 rather than contradicting it. Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #70 · Access › Insurance & coverage · 15 Dec 2024 · 0 likes post #69 answers the question as asked. The question underneath it is different. Formulary status: the list of covered medications and the tier (how much you pay) they…
-
Coming back to: When to suspect the method rather than the sample Replied, post #39 · Analytics › Method validation · 7 Dec 2024 · 18 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Started this topic · Clinical › Comorbidities · 30 Nov 2024 · 3 likes On the subject in the title: Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Working notes rather than a conclusion. General question, not…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #22 · Practice › Side effects · 24 Nov 2024 · 1 like Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #40 · Compounds › Semaglutide · 23 Nov 2024 · 0 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #5 · Evidence › Journal club · 21 Oct 2024 · 1 like SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Gallbladder disease risk with rapid weight loss Replied, post #21 · Clinical › Comorbidities · 19 Oct 2024 · 17 likes Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the…
-
Food noise reducing and the disorientation that can follow Replied, post #23 · Wellbeing › Mental health · 16 Oct 2024 · 31 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
When "no data" is the complete and final answer Replied, post #4 · marked as the solution · Compounds › Other compounds · 15 Oct 2024 · 8 likes On post #2 — agreed on the reasoning, with one qualification. Research-use-only status is a legal classification, not a safety classification. It means the compound is…
-
A page that has drifted out of date and needs a maintainer Replied, post #13 · Documentation › Wiki requests · 27 Sep 2024 · 0 likes I read post #11 twice before replying, because I had assumed the opposite. Accessibility feedback: if you have trouble accessing or reading a maintained page (screen…
-
Correlation in a self-tracked dataset: what it can support Replied, post #108 · Research Methods › Statistics · 24 Aug 2024 · 12 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Blind submission and why it changes minds Replied, post #39 · Sourcing › Independent verification · 18 Aug 2024 · 12 likes post #38 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #26 · Analytics › COA interpretation · 12 Aug 2024 · 24 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Guidelines revision: what changed and why Replied, post #100 · Meta › Announcements · 28 Jul 2024 · 6 likes On post #96 — agreed on the reasoning, with one qualification. Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here…
-
Cold packs, phase-change material, and what survives ten days Replied, post #139 · Sourcing › Logistics · 24 Jul 2024 · 12 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…